Loading company…
Riskpilot
← Back to search
Sign in
Get full access
FAIZI MEDISINSKE AS
AS
Active
Org 931702807
Ekornveien 10A, 1785 Halden
General medical practice activities · NACE 8621
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 4,6M
-9% vs 2024
EBITDA margin
45.1%
+1% vs 2024
Equity ratio
33.8%
Financial strength
Net profit 2025
NOK 1,4M
+3% vs 2024
EBITDA — year on year
NOK millions
3M
2M
1M
1M
0M
1M
2023
2M
+100%
2024
2M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 4,6M
-9%
EBITDA
NOK 2,1M
+1%
Net profit
NOK 1,4M
+3%
Total assets
NOK 2,8M
-20%
Equity
NOK 959K
-52%
Employees
0
—
Company information
Legal name
FAIZI MEDISINSKE AS
Org number
931702807
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
11. juli 2023
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Utøvelse av legevirksomhet og andre tjenester som naturlig hører til dette, herunder å delta i andre selskap med lignende virksomhet.
Contact
Address
Ekornveien 10A, 1785 Halden
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Halden
All Norway companies
Revenue
NOK millions
0M
1M
3M
4M
6M
2M
2023
5M
2024
5M
2025
EBITDA
NOK millions
0M
1M
1M
2M
2M
1M
2023
2M
2024
2M
2025
Income statement
NOK thousands
Item
2023
2024
2025
Revenue
2 344
5 013
4 566
Staff expenses
−846
−1 633
−904
EBITDA
1 070
2 042
2 059
Depreciation & amort.
−111
−220
−236
EBIT
959
1 822
1 823
Net financials
−2
−32
27
Profit before tax
957
1 790
1 850
Tax
211
394
408
Net profit
747
1 396
1 442
Balance sheet
NOK thousands
Item
2023
2024
2025
Total assets
2 269
3 566
2 836
Equity
621
2 017
959
Long-term debt
1 024
805
0
Short-term debt
624
745
1 878
Total debt
1 648
1 550
1 878
Financial ratios
5-year trend
EBITDA margin
45.1%
This company
15.8%
Market median
+185% vs market
2023
2025
Equity ratio
33.8%
This company
38.2%
Market median
+12% vs market
2023
2025
Return on equity
150.4%
This company
18.4%
Market median
+717% vs market
2023
2025
Net profit margin
31.6%
This company
8.1%
Market median
+290% vs market
2023
2025
Asset turnover
1.61×
This company
1.12×
Market median
+44% vs market
2023
2025
Debt / equity
1.96×
This company
0.62×
Market median
-216% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-06-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
AM
Atal Mohammad Feroz Faizi
Chairman
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Atal Holding As
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Atal Holding As
FAIZI MEDISINSKE AS
(this company)
Board network connections
Board members of FAIZI MEDISINSKE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Atal Mohammad Feroz Faizi
Chairman
0 companies